Tempus AI Pre-Tax Income 2023-2024 | TEM

Tempus AI annual/quarterly pre-tax income history and growth rate from 2023 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
  • Tempus AI pre-tax income for the quarter ending December 31, 2024 was $-0.010B, a 79.4% decline year-over-year.
  • Tempus AI pre-tax income for the twelve months ending December 31, 2024 was $-0.701B, a 228.44% increase year-over-year.
  • Tempus AI annual pre-tax income for 2024 was $-0.701B, a 228.44% increase from 2023.
  • Tempus AI annual pre-tax income for 2023 was $-0.214B, a 26.15% decline from 2022.
  • Tempus AI annual pre-tax income for 2022 was $-0.289B, a 0% decline from .
Tempus AI Annual Pre-Tax Income
(Millions of US $)
2024 $-701
2023 $-214
2022 $-289
Tempus AI Quarterly Pre-Tax Income
(Millions of US $)
2024-12-31 $-10
2024-09-30 $-74
2024-06-30 $-552
2024-03-31 $-65
2023-12-31 $-50
2023-09-30 $-53
2023-06-30 $-56
2023-03-31 $-54
2022-12-31
Sector Industry Market Cap Revenue
Medical MEDICAL INFO SYS $9.826B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) US $38.476B 53.14
Hims & Hers Health (HIMS) US $9.069B 145.79
Inspire Medical Systems (INSP) US $4.756B 92.38
IRhythm Technologies (IRTC) US $4.185B 0.00
Privia Health (PRVA) US $2.829B 212.00
Enovis (ENOV) US $2.016B 12.47
Schrodinger (SDGR) US $1.847B 0.00
Clover Health Investments (CLOV) US $1.706B 0.00
Phreesia (PHR) US $1.512B 0.00
Omnicell (OMCL) US $1.460B 31.47
Azenta (AZTA) US $1.232B 57.36
10x Genomics (TXG) US $1.031B 0.00
Fulgent Genetics (FLGT) US $0.634B 0.00
Butterfly Network (BFLY) US $0.566B 0.00
Talkspace (TALK) US $0.537B 319.00
Veradigm (MDRX) US $0.476B 0.00
Standard BioTools (LAB) US $0.456B 0.00
TruBridge (TBRG) US $0.392B 0.00
Claritev (CTEV) US $0.362B 0.00
Health Catalyst (HCAT) US $0.294B 0.00
Nyxoah SA (NYXH) BE $0.208B 0.00
SOPHiA GENETICS SA (SOPH) CH $0.202B 0.00
Pulmonx (LUNG) US $0.152B 0.00
American Well (AMWL) US $0.116B 0.00
EUDA Health Holdings (EUDA) SG $0.097B 0.00
Retrieve Medical Holdings (RMHI) US $0.085B 0.00
MDxHealth SA (MDXH) BE $0.081B 0.00
CareCloud (CCLD) US $0.080B 3.43
111 (YI) CN $0.072B 0.00
P3 Health Partners (PIII) US $0.063B 0.00
HeartBeam (BEAT) US $0.061B 0.00
Outset Medical (OM) US $0.044B 0.00
Zepp Health (ZEPP) CN $0.039B 0.00
Zhongchao (ZCMD) CN $0.029B 0.00
ImmunoPrecise Antibodies (IPA) CA $0.021B 0.00
Bullfrog AI Holdings (BFRG) US $0.017B 0.00
MSP Recovery (MSPR) US $0.016B 0.00
Streamline Health Solutions (STRM) US $0.013B 0.00
Precipio (PRPO) US $0.011B 0.00
Strata Skin Sciences (SSKN) US $0.011B 0.00
Predictive Oncology (POAI) US $0.010B 0.00
Healthcare Triangle (HCTI) US $0.009B 0.00
Movano (MOVE) US $0.006B 0.00
Mobile-health Network Solutions (MNDR) SG $0.005B 0.00
HeartSciences (HSCS) US $0.004B 0.00
Tivic Health Systems (TIVC) US $0.003B 0.00
Future Health ESG (FHLT) US $0.000B 0.00